Graticule Asia Macro Advisors’s Biogen BIIB Stock Holding History

Graticule Asia Macro Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-800	Closed	-$283K	–	98
2018 Q3	$283K	Hold	800	–	–	0.02%	208
2018 Q2	$232K	Buy	+800	New	+$225K	0.01%	147
2017 Q2	–	Sell	-24,795	Closed	-$6.78M	–	116
2017 Q1	$6.78M	Buy	+24,795	New	+$7.01M	0.39%	60
2016 Q4	–	Sell	-28,000	Closed	-$8.77M	–	112
2016 Q3	$8.77M	Buy	+28,000	New	+$8.29M	0.62%	30
2016 Q1	–	Sell	-7,796	Closed	-$2.06M	–	94
2015 Q4	$2.39M	Buy	7,796 +1,296	+20%	+$372K	0.39%	47
2015 Q3	$1.9M	Buy	+6,500	New	+$2.15M	0.22%	53

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Graticule Asia Macro Advisors's BIIB Position: Q4 2018 in Review

Graticule Asia Macro Advisors sold out of Biogen (BIIB) in Q4 2018, closing a stake of 800 shares — an estimated $283K sold.

Graticule Asia Macro Advisors first reported a position in BIIB in Q3 2015 and held it in 6 quarters. The position peaked at $8.77M in Q3 2016. 1,140 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.

Graticule Asia Macro Advisors reported no remaining Biogen position as of Q4 2018 after selling out during the quarter.
Graticule Asia Macro Advisors sold 800 Biogen shares in Q4 2018, an estimated $283K.
Graticule Asia Macro Advisors first reported a position in Biogen in Q3 2015 and held it in 6 quarters.
Graticule Asia Macro Advisors's Biogen position peaked at $8.77M in Q3 2016.
1,140 funds tracked by Wall St. Rank held Biogen as of Q4 2018.

Based on Graticule Asia Macro Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.